Phase 2 Study of Ivonescimab in Patients With Cutaneous Squamous Cell Carcinoma

Clinical trial NCT06567314 · RECRUITING

Trial details

NCT number: NCT06567314
Sponsor: M.D. Anderson Cancer Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Cutaneous Squamous Cell Carcinoma

Start date: 2024-12-02
Primary completion: 2028-09-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.